Bios Equity Partners LP 13D and 13G filings for Lantern Pharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-03-01 4:10 pm Sale |
2024-02-28 | 13D | Lantern Pharma Inc. LTRN |
Bios Equity Partners LP | 1,263,802 11.800% |
-202,889 (-13.83%) |
Filing |
| 2023-12-01 06:02 am Sale |
2023-11-29 | 13D | Lantern Pharma Inc. LTRN |
Bios Equity Partners LP | 1,466,691 13.600% |
-508,150 (-25.73%) |
Filing |
| 2022-03-22 4:15 pm Purchase |
2022-03-17 | 13D | Lantern Pharma Inc. LTRN |
Bios Equity Partners LP | 1,974,841 18.100% |
5,855 (+0.30%) |
Filing |
| 2020-06-23 3:17 pm Purchase |
2020-06-15 | 13D | Lantern Pharma Inc. LTRN |
Bios Equity Partners LP | 1,968,986 30.600% |
1,968,986 (New Position) |
Filing |